Prior authorization · Post-decision
Appeals
Denied authorizations and where each appeal stands
PreviewNot in this phase. Appeal drafting and tracking for denied authorizations. Static sample data; rows open a read-only detail.
Open appeals
4
1 due this week
Overturned YTD
11 of 16
69%
Avg days to decision
23
internal level 1
Top denial reason
Dosimetry
7 of 16 cite the comparison plan
Denials and appeals
5 rows
| Patient | Payer | Site | Denied | Denial reason | Level | Due | Status |
|---|---|---|---|---|---|---|---|
| Harold Beck | UHC · Choice Plus | Oropharynx | 2026-09-02 | Comparison plan did not report mean parotid dose | Level 1 internal | 2026-10-02 | Drafting |
| Denise Oyelaran | Aetna · Open Access PPO | Right breast | 2026-08-21 | Not medically necessary: right-sided breast | Level 2 internal | 2026-10-15 | Submitted |
| Luis Arroyo | Cigna · Open Access Plus | Prostate | 2026-07-30 | Considered experimental for prostate | External (IRO) | 2026-10-20 | Awaiting IRO |
| Joan Pruitt | Humana · Gold Plus HMO | Lung | 2026-08-28 | Performance status not documented | Reconsideration | 2026-10-06 | Overturned 9/25 |
| Tomasz Nowak | BCBS TX · Blue Choice PPO | Esophagus | 2026-09-10 | Insufficient dosimetric comparison | Level 1 internal | 2026-10-09 | P2P requested |